Shortly after becoming the youngest stand-up comedian in history to sell out the Hollywood Bowl during the second installment of Netflix is a Joke in May, Matt Rife’s tireless pursuit of success ...

"I know I can't be the only person in this room who strives for something that might seem impossible." In a packed house at The Comedy Zone in Charlotte, comedian Matt Rife is about to make Netflix ...

Matt Rife defended his fame and comedic style in the first trailer for his second Netflix special, "Lucid," released Thursday. "Next time you guys see some haters in my comments going, 'All he does is ...

Matt Rife is a “comedian” who, often, uses his crowd work to make people think he’s good at stand-up. So when his stand-up specials inevitably failed, people realized quickly that he isn’t as funny as ...

Comedian Matt Rife is returning to Netflix with his second special for the streamer this week, this time focused entirely on crowd work. Who knows what “Lucid” will be? Well, you might have an idea if ...

More Matt Rife is coming to Netflix. Following his comedy special “Natural Selection” in November 2023, Rife will make two more specials on Netflix. The first in Rife’s two-special deal is set to ...

Sarah Ailwood does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

“This is going terribly,” Matt Rife announces at his ProbleMATTic show at Los Angeles’ Dolby Theater. “This” is a repartee with a young female fan, who initially interjected to reveal that the two ...

Vivid Seats is the New York Post's official ticketing partner. We may receive revenue from this partnership for sharing this content and/or when you make a purchase. Ticket prices to see Matt Rife are ...

For a full hour at The Comedy Zone in Charlotte, North Carolina, Matt Rife relied solely on his audience to keep his show afloat. The comedian spent the duration of his set engaging with the crowd, ...

Social media claims that research by American inventor Royal Raymond Rife in the 1920s and 1930s -- as well as modern techniques that use targeted low-frequency energy -- represent a workable cancer ...